Teva Pharmaceutical Industries Limited Sponsored ADR Stock

$16.94

0.41% day before yesterday

NYSE, May 16, 10:10 pm CET

ISIN

US8816242098

Symbol

TEVA

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Teva Pharmaceutical Industries Limited Sponsored ADR Stock price

$16.94

+5.17 43.93% 5Y

NYSE, Closing price Fri, May 16 2025

+0.07 0.41%

ISIN

US8816242098

Symbol

TEVA

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Health

Industry

Pharmaceuticals

Key metrics

Market capitalization	$19.41b
Enterprise Value	$34.66b
P/E (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	16.64
EV/Sales (TTM) EV/Sales	2.09
P/S ratio (TTM) P/S ratio	1.17
P/B ratio (TTM) P/B ratio	3.10
Revenue growth (TTM) Revenue growth	3.38%
Revenue (TTM) Revenue	$16.56b
EBIT (operating result TTM) EBIT	$3.38b
Free Cash Flow (TTM) Free Cash Flow	$2.08b
Cash position	$1.70b
EPS (TTM) EPS	$-1.14
P/E forward	7.55
P/S forward	1.14
EV/Sales forward	2.03
Short interest	2.49%

As a Free StocksGuide user, you can view scores for all 6,790 stocks worldwide.

Get Started for Free Today

Teva Pharmaceutical Industries Limited Sponsored ADR Stock Analysis

Unlock Scores for Free

??

10 Analysts have issued a Teva Pharmaceutical Industries Limited Sponsored ADR forecast:

8x Buy

80%

More details on Analyst Estimates Including Price Targets

10 Analysts have issued a Teva Pharmaceutical Industries Limited Sponsored ADR forecast:

Buy

80%

Hold

10%

Sell

10%

Analyst Estimates with Stock Price Targets

Financial data from Teva Pharmaceutical Industries Limited Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	16,563 16,563	3% 3% 100%
- Direct Costs	8,446 8,446	3% 3% 51%
Gross Profit	8,117 8,117	3% 3% 49%
- Selling and Administrative Expenses	2,703 2,703	12% 12% 16%
- Research and Development Expense	1,004 1,004	4% 4% 6%
EBITDA	4,410 4,410	1% 1% 27%
- Depreciation and Amortization	1,031 1,031	8% 8% 6%
EBIT (Operating Income) EBIT	3,379 3,379	1% 1% 20%
Net Profit	-1,285 -1,285	179% 179% -8%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Teva Pharmaceutical Industries Limited Sponsored ADR Stock News

Neutral

GlobeNewsWire

●

3 days ago

Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy

TEL AVIV, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals (NYSE and TASE: TEVA) today announced that Moody's Investor Services (“Moody's”) has raised the company's corporate credit rating to Ba1, outlook stable; from Ba2, outlook positive. Moody's report cites the Company's strengths which include significant global scale, ongoing growth in the company's branded franchises, stabil...

Positive

The Motley Fool

●

6 days ago

Why Teva Pharmaceuticals Stock Blasted 6% Higher Today

A positive change in recommendation from a well-known bank was the fuel propelling Teva Pharmaceutical Industries's (TEVA 5.82%) well higher on Monday. The company, known for being a top producer of generic drugs, saw its share price swell almost 6% as a result.

Positive

Seeking Alpha

●

10 days ago

Teva's Transformation: Why This 'Forgotten Pharma' Could Deliver 30% Upside

Teva's betting big on biosimilars and specialty drugs, with AUSTEDO and UZEDY leading the charge. Management's $700 million cost-cutting plan is on track, aiming for a 30% operating margin by 2027. Recent FDA wins, like SELARSDI, show Teva's pushing into high-margin markets.

More Teva Pharmaceutical Industries Limited Sponsored ADR News

Company Profile

Teva Pharmaceutical Industries Ltd. engages in the development and production of medicines. Its products include medicines for cardiovascular diseases, pain relievers, obesity, cancer and supportive care, infectious diseases and human immunodeficiency viruses, and colds and coughs. The company was founded in 1901 and is headquartered in Petah Tikva, Israel.

Head office	Israel
CEO	Richard Francis
Employees	36,167
Founded	1901
Website	www.tevapharm.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now